The Inspiring Leaders Podcast - The landscape for businesses in 2024


Exploring the landscape for businesses in 2024, this episode is part of Criticaleye's Inspiring Leaders Podcast series. Featuring Criticaleye Host and Director of Content, Marc Barber, and special guest Matthew Blagg, CEO, Criticaleye. Talking points include:

  • The uncertain geopolitical landscape and how businesses are tackling a high interest rate and inflation environment.
  • How can Boards keep up with the current economic trends.
  • The latest tech trends and is there a knowledge gap within Boards?
  • What should leaders prioritise in 2024, and what’s on the people agenda?
  • What next year will bring for private equity backed companies.
  • What areas can Boards be optimistic within the next twelve months?


Share this with your Community




Click here to download this insight

DOWNLOAD PODCAST



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
AlixPartners Disruption Index...

Disruption remains a constant in business today, but leaders are becoming more adept at navigating it. With geopolitical tensions, tariffs and energy pressures persisting, the real divide is emerging around AI. The 2026...

Inspiring leaders Podcast: Th...

Alastair Mills, Managing Director & Head of European Business Services at H.I.G. Capital, joins Criticaleye’s Senior Editor Jacob Ambrose Willson to share his perspective on what lies ahead...

Inspiring Leaders Podcast: Wh...

Matthew Blagg, CEO for Criticaleye, joins Marketing and Communications Director Julia Brook for the first Inspiring Leaders podcast for 2026. They take a look at some of the lessons for leaders last year, and examin...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 224




NATS E.ON UK AlixPartners British Land FTSE Women Leaders Review Worldpay London Stock Exchange Group Google Legal & General Rolls-Royce Aldermore Group Drax Group plc NatWest Group Hitachi Solutions Lightsource bp Workday GlaxoSmithKline plc